Insights From a Fish Might Help People Battling Spinal Cord Injury
By Dennis Thompson HealthDay Reporter
MONDAY, Aug. 19, 2024 -- A fish might hold clues to healing spinal cord injuries in humans, researchers report.
The damaged nerve cells of zebrafish can survive a spinal cord injury, eventually restoring full movement in the fish.
That’s very unlike humans and most other mammals, in which damaged neurons always die, researchers said.
But the way the zebrafish neurons first survive and then heal run counter to some of the ways in which research efforts are trying to treat spinal cord injuries in humans, the new study says.
Damaged neurons in a zebrafish’s spinal cord dramatically alter their function, with a focus on survival. They then take on new roles in guiding the precise events that guide healing.
“In zebrafish, we think severed neurons can overcome the stress of injury because their flexibility helps them establish new local connections immediately after injury,” said senior researcher Mayssa Mokalled, an associate professor of developmental biology with the Washington University School of Medicine in St. Louis.
“Our research suggests this is a temporary mechanism that buys time, protecting neurons from death and allowing the system to preserve neuronal circuitry while building and regenerating the main spinal cord,” Mokalled added in a university news release.
This is very different from the way human neurons respond to injury. When the spinal cord is crushed or damaged, it sets off a toxic chain of events that kills the neurons and suppresses repair mechanisms, researchers said.
This toxic response could explain why efforts to heal spinal cord injuries using experimental stem cell therapy has failed, researchers said.
Instead of focusing on regenerating neurons using stem cells, any successful method of healing spinal cord injuries in humans must start with saving the injured neurons from death, researchers said.
“We found that most, if not all, aspects of neural repair that we’re trying to achieve in people occur naturally in zebrafish,” Mokalled said.
“The surprising observation we made is that there are strong neuronal protection and repair mechanisms happening right after injury,” Mokalled noted. “We think these protective mechanisms allow neurons to survive the injury and then adopt a kind of spontaneous plasticity -- or flexibility in their functions -- that gives the fish time to regenerate new neurons to achieve full recovery.”
There’s some evidence that such nerve cell healing is possible but dormant in mammals, researchers said. That could provide a new route to therapies that would successfully heal spinal cord injuries.
“Our study has identified genetic targets that will help us promote this type of plasticity in the cells of people and other mammals,” Mokalled said. “We are hopeful that identifying the genes that orchestrate this protective process in zebrafish -- versions of which also are present in the human genome -- will help us find ways to protect neurons in people from the waves of cell death that we see following spinal cord injuries.”
Researchers plan to follow up by focusing on the contributions of other cell types to spinal cord regeneration, and to compare what they found in zebrafish to the cells of mammals.
The new study appears Aug. 15 in the journal Nature Communications.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-20 03:15
Read more
- Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
- FDA Approves Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
- ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
- Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
- Could Certain Genes Help You Slim Down?
- First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions